Navigation Links
Research shows biopsy of recurrent breast cancer can alter treatment
Date:3/18/2009

(Toronto March 18, 2009) For women with recurrent breast cancer, the treatment the doctor chooses is usually based on the properties of their original breast cancer. A group from Toronto has recently completed the world's first study that compared original breast cancer tumors with a biopsy of suspected tumors that recurred elsewhere in the body.

Researchers found that the biopsy resulted in 20% of the women having a significant change in their treatment. In some cases, this was a change in drug treatment and in others, the biopsy showed the woman did not actually have an advanced cancer, but a benign condition.

"The results show that cancers may change over time and not respond to treatment that was appropriate for the original cancer," says principal investigator Dr. Mark Clemons, a medical oncologist specializing in breast cancer in the Princess Margaret Hospital Cancer Program, University Health Network (UHN).

"These early findings are leading us in a new direction as we understand more about why some women don't respond to treatment. This knowledge will help us in our quest to always deliver the right treatment, to the right patient, at the right time."

The findings are published online today in the Annals of Oncology, Oxford University Press (Doi:10.1093/annonc/mdp028).

Dr. Clemons's study -- funded by a $100,000 research grant from the Canadian Breast Cancer Foundation - Ontario Region -- evaluated 29 biopsies of accessible, recurrent tumors taken from women whose breast cancer had spread to bone, skin, lymph nodes, lung or liver.

Pathologists compared the results of the original cancer with the results of the new biopsy by analyzing the predictive markers that influence breast cancer tumor growth estrogen, progesterone and Her2 status. The presence, absence and/or combinations of these markers become the map oncologists use to determine the most effective treatment for each patient.<
'/>"/>

Contact: Jane Finlayson
jane.finlayson@uhn.on.ca
416-946-2846
University Health Network
Source:Eurekalert

3

GOOD

Page: 1 2

Related medicine news :

1. Georgia State/Georgia Tech Center for Advanced Brain Imaging to expand brain, mind research
2. Conflicts of interest in clinical research
3. Stimulus Spending Targets Modernization of the Nation's Research Infrastructure
4. Researchers Use Gene to End High Blood Sugar in Mice
5. Major Asthma Research Discovery Could Lead to New Drugs
6. Penn researchers identify new protein important in breast cancer genes role in DNA repair
7. New research suggests common anti-seizure medications may increase risk of cardiovascular problems
8. Researcher wins $2.6 million grant for depression care study
9. Frost and Sullivan Picks Epinex for Diabetes Research Award
10. Foundation for Biomedical Research Releases Groundbreaking PSA
11. Fish health claims may cause more environmental harm than good: UBC-St. Michaels researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2010)... financial rating tools are reliable , , WEDNESDAY, March ... not help reduce U.S. health-care costs, a new ... incentives and other methods to encourage patients to ... lower are becoming increasingly common. But these efforts ... doctor performance and may not achieve the intended ...
(Date:3/17/2010)... so do the number of heart attack survivors, ... News) -- The availability of public automated external ... heart attack with little neurological consequences, suggests new ... available nationwide, a study found that about 14 ... from an irregular heart rhythm survived with a ...
(Date:3/17/2010)... Celebrating "The Autism Connection: Horses ... (TERI) is pleased to announce that Rupert ... The Horse Boy, will be guest speaker ... Tournament Fundraiser.  The two-day event kicks-off with the ... of his family,s epic journey of personal and ...
(Date:3/17/2010)... , ... , , ... ... ... MINNEAPOLIS , March 17 The Society of Corporate Compliance and Ethics (SCCE) announced it will testify on its behalf and ...
(Date:3/17/2010)... physicians and affiliated clinicians for U.S. HealthWorks Medical Group participated ... featuring innovators in healthcare research and delivery. , ... ... More than 250 physicians and affiliated clinicians for U.S. ... Medical Symposium in Pasadena, CA featuring innovators in healthcare research ...
Breaking Medicine News(10 mins):Health News:Ranking Doctors by Cost-Profile May Not Help Save Money 2Health News:Widespread Public Defibrillators May Save Lives 2Health News:Widespread Public Defibrillators May Save Lives 3Health News:Rupert Isaacson, Author/Star of Sundance Film Official Selection 'The Horse Boy' to Speak at 20th Annual Fundraiser 2Health News:Rupert Isaacson, Author/Star of Sundance Film Official Selection 'The Horse Boy' to Speak at 20th Annual Fundraiser 3Health News:Rupert Isaacson, Author/Star of Sundance Film Official Selection 'The Horse Boy' to Speak at 20th Annual Fundraiser 4Health News:Society of Corporate Compliance and Ethics Testifies at U.S. Sentencing Commission March 17, 2010 Hearing on Proposed Amendments 2Health News:Society of Corporate Compliance and Ethics Testifies at U.S. Sentencing Commission March 17, 2010 Hearing on Proposed Amendments 3Health News:Society of Corporate Compliance and Ethics Testifies at U.S. Sentencing Commission March 17, 2010 Hearing on Proposed Amendments 4Health News:Society of Corporate Compliance and Ethics Testifies at U.S. Sentencing Commission March 17, 2010 Hearing on Proposed Amendments 5Health News:Innovative Healthcare Symposium Held By U.S. HealthWorks 2
... to researchers, Australian men's attitudes to hormonal contraception has ... shoulder the responsibility. The researchers, from the Department of ... the male partners //of women who had recently given ... about a male contraceptive hormone. ,Dr Grath Weston ...
... study, estrogen replacement therapy does not reduce post-menopausal women's ... for Stroke Trial (WEST) is the recent study to ... therapy, or HRT, on the heart and blood vessels. ... that a lot of people thought estrogen was ...
... the contrary, researchers reported, that mild depression may probably ... University Medical Center in Durham, studied 3500 men and ... three years from 1989 to 1999. The interview subjects ... participants were married, some widowed and some divorced. Some ...
... animals, the curry spice turmeric may help reduce ... spice contains curcumin, a compound thought to be ... ,Dr. Ken Sugimoto, of the department of internal ... Japan, showed that curcumin can improve experimental colitis. ...
... of Texas, exercise during treatment for breast cancer can ... of life measures. Roenann Roubenoff, from Tufts University, presented ... Dr. Roubenoff stood in, as the researchers were unable ... It's a nice adjunct to therapy and people can ...
... study, organically-grown oranges have up to 35% more vitamin C ... that organic produce must be better for you. Scientific evidence ... and chemists at the University of Texas have analysed organic ... ,They find the organic ones contain a three times more ...
Other Medicine News:Health News:Men happy to take contraception 2Health News:Possible benefits of Hormone Replacement Therapy 2Health News:Mild Depression may guard aged women 2Health News:Exercise for patients with cancer 2
(Date:3/17/2010)... March 17 Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food ... ... , , ... ... ...
(Date:3/17/2010)... Fourteenth Annual New York Emerging Growth Institutional Investor Forum at The Grand Hyatt in New York City on Tuesday, March 23, 2010 . ... ... ... ... Joseph W. Kaufmann , Kensey Nash ...
(Date:3/17/2010)... North America ,s leading healthcare Network, has another solution for the down economy. , ... , , ... ... ... ...
Breaking Medicine Technology:Actavis Receives Approval of Alprazolam ODT in the U.S. 2Actavis Receives Approval of Alprazolam ODT in the U.S. 3Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum 2Healthcare Web Site Expands Reach to Pharmacy Industry 2Healthcare Web Site Expands Reach to Pharmacy Industry 3Healthcare Web Site Expands Reach to Pharmacy Industry 4Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 4598 1Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 4598 2Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 4598 3Good news for some hard to treat hepatitis C patients 49004 1Good news for some hard to treat hepatitis C patients 49004 2Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 1Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 2Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 3Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 4Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 5Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 6
... Study shows paroxetine produced no significant drug ... 2007 /PRNewswire/ -- After administration of,paliperidone extended-release ... not affected when given with a common ... the 160th Annual Meeting,of the American Psychiatric ...
... -- Data from Picoplatin Phase 1 Colorectal and ... Proceedings --, SOUTH SAN FRANCISCO, Calif., May 23, ... company,focused on oncology, today announced that data from ... product candidate, in patients,with small cell lung cancer ...
Other Medicine Technology:Blood Levels of Paliperidone Extended-Release Tablets are Not,Increased by Common Antidepressant 2Blood Levels of Paliperidone Extended-Release Tablets are Not,Increased by Common Antidepressant 3Blood Levels of Paliperidone Extended-Release Tablets are Not,Increased by Common Antidepressant 4Blood Levels of Paliperidone Extended-Release Tablets are Not,Increased by Common Antidepressant 5Blood Levels of Paliperidone Extended-Release Tablets are Not,Increased by Common Antidepressant 6Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 3Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 4
... Knee CR system was designed to ... femoral joint has a recessed, deepened ... advancement of the patella, which has ... The anatomic groove promotes more normal ...
... Biopro TKO implant is among ... implants available. The TKO preserves ... ligaments. The implant provides a ... while preserving bone and relieving ...
... The Maxim® Knee System's curved-on-curved articulation ... excellent sizing options for better patient fit. ... combination of AGC® knee's proven concepts with ... indications. The Maxim is indicated for ...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively, right up until the definitive implants are to be put i...
Medicine Products: